pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3616 |
Genomic Coordinates | chr20: 47166967 - 47167058 |
Description | Homo sapiens miR-3616 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3616-3p | |||||||||||||||||||||
Sequence | 60| CGAGGGCAUUUCAUGAUGCAGGC |82 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RPS24 | ||||||||||||||||||||
Synonyms | DBA3, S24 | ||||||||||||||||||||
Description | ribosomal protein S24 | ||||||||||||||||||||
Transcript | NM_001142285 | ||||||||||||||||||||
Other Transcripts | NM_001026 , NM_001142282 , NM_001142284 , NM_001142283 , NM_033022 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RPS24 | |||||||||||||||||||||
3'UTR of RPS24 (miRNA target sites are highlighted) |
>RPS24|NM_001142285|3'UTR 1 TGTCACTGCCATGGCCGCCTTGCTGCATTTCTGAGGATGCTTCATCTCTCCACCTTCTTCTCCACTCAGCAGCCAGCAGG 81 GCACTGTGGAAATCGGAGTCACATGAGCTGGCACCTCTGTTCAGAACCCTCCAGGGCTCCACATCTCTCTCACCCAAATG 161 CCAAAGACCTCCCCACGCCCCCACAATCCCCCACGACCTGGCCACTGGCCTCCCACCACCTTCCAGCTCCAGCGGCTCCT 241 ACCACATTTAAGGCTTTCCTTCCTAGTTTTAATTTTTCCTCGTCAGCAGTTGATTTTATTATTTTCTTGTTTATTGGTAT 321 TTTCCCACTAGAAATGAAGCTGCGTGAAGTTAGAGATTTTTTTTTTTGGTCTGTGTTCCTAATTAGCTCATTGCTATACC 401 CCTGGCGCCCAGAACAATGCCTTGGACACAGTACGCAGTAGACTAAATAAATACTTGTTGAATGACTGACTGACGGAATG 481 ACGGCTGTGTGGGGAGTGGATTGGGTCGTGAGGCAGAGGCTGCGGTGGAAACTCAGGCAGGAGGTGATGGTGGTTCTTGG 561 GGCTGCGGAATGCCAAGTTTAGAAGCTCTTCCTCTGCTGTGGCACATGAACCGGTCACTCGAGAAGGCTTTTAGATTTAC 641 TTTGCCTAATCCCCTCTTAGTGCATGTGGGGAAACTGAGGTACACAAAAGGAATTCCCCACCAAGTTAGGGGCAGAACCT 721 AGCCCCCTTGTCTCCCAGATGGATATCTTCTTTTTTTTTTGAGACGGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGCAGT 801 GGTACCATCTTGGCTCACTGCAACCTCTGCTTCCCAGGTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTGTCTGCGAT 881 TACAGGTGCACACAACCACGCCTGGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCGTGTTGGTCAGGGTGACC 961 TCAAACTCCTGACCTCATGATCCACCCAGCTCAGCCTCCCAACGTGCTGGGATTACAGGCATGAGCCACCGTGCCTGGCT 1041 GGACATCTTGTTATTAAAGCTTCTTCTCTCTTTGTAGGGGAGGGGGAGATGCCTCTGGTGGAGAAGACCAGTGTGGCAGT 1121 GACTGTGTCTGTTAGTGAACCTGGTGGCTGGTTGAGGGTCTGTCGTGGTGACTGAGGACACATACAAAGTGCTTTTCTCA 1201 GTGGTCACCTTGGTGTTGGTGAATAAGGGTCAGAAGATGGCTCCTGTCCTAGGGCACTGCCAGTCGGTTTGGAAGCTGAA 1281 ATGCCTGCTTAGCAGTTTGAGGAAACACAGACCTTGGAGGATCTTCTGGTTGCCTCTTCAAGAATTCATTCTATTCCCCT 1361 TCTGCTCCCCAAATTTGCTTTTCTTGGGGTGGGTCTTGGTTGGCCTAAGCCAAGAAAGTATGGCATCTACTCCTTCCATA 1441 GCAATAGCTCAGGAATAGGCAGTGACCCAGACCTGAACCAATCAGTGCATGGAATTACCCCTGGCCAAAGTGGTTGATTG 1521 AGGCTGGGTGCAAGCAGAGTTGTGAGAAGGCTCCCATTTGGTGGTTGGAGAGATCGCACTTGCTCCAGAGGTCATAATGT 1601 GCAGATCTGAGGCTTGGAACTGCTGCAGACATTTTGCTACCACAAGTGAAGCCACCCTGACGACACAGTTGACAATTTGG 1681 AGCAGGGCAGAGCTGAGAGAACAGCAGGGAAACAGCCAGAGTCTTGCTCAAGCCTCCCTGAAGTATCTATACCCCTGGAC 1761 TCTAGTTATGGGGGCTAATAAATGTTATATACTGTTTAAGGTAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000435275.1 | 3UTR | ACACCCUCCUCUACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
65 hsa-miR-3616-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT064769 | CCND2 | cyclin D2 | 2 | 2 | ||||||||
MIRT066953 | ATXN7L3B | ataxin 7 like 3B | 2 | 8 | ||||||||
MIRT109451 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT110074 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | 2 | 2 | ||||||||
MIRT253112 | BCL2L12 | BCL2 like 12 | 2 | 2 | ||||||||
MIRT444698 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | 2 | 2 | ||||||||
MIRT445748 | AGO1 | argonaute 1, RISC catalytic component | 2 | 2 | ||||||||
MIRT446453 | CHST15 | carbohydrate sulfotransferase 15 | 2 | 2 | ||||||||
MIRT451956 | TMPRSS5 | transmembrane protease, serine 5 | 2 | 2 | ||||||||
MIRT452332 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT453115 | HOXC4 | homeobox C4 | 2 | 2 | ||||||||
MIRT455167 | SUV39H1 | suppressor of variegation 3-9 homolog 1 | 2 | 2 | ||||||||
MIRT457105 | DCX | doublecortin | 2 | 2 | ||||||||
MIRT458349 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | 2 | 2 | ||||||||
MIRT461635 | ZSWIM4 | zinc finger SWIM-type containing 4 | 2 | 2 | ||||||||
MIRT462354 | BCL7B | BCL tumor suppressor 7B | 2 | 2 | ||||||||
MIRT462750 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT465801 | TMEM91 | transmembrane protein 91 | 2 | 2 | ||||||||
MIRT468741 | SDC2 | syndecan 2 | 2 | 2 | ||||||||
MIRT468935 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT469166 | RNF111 | ring finger protein 111 | 2 | 2 | ||||||||
MIRT469466 | REEP5 | receptor accessory protein 5 | 2 | 2 | ||||||||
MIRT469605 | RALGAPA2 | Ral GTPase activating protein catalytic alpha subunit 2 | 2 | 2 | ||||||||
MIRT470600 | POTEM | POTE ankyrin domain family member M | 2 | 2 | ||||||||
MIRT470630 | POTEG | POTE ankyrin domain family member G | 2 | 2 | ||||||||
MIRT471061 | PIM2 | Pim-2 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT473179 | MLEC | malectin | 2 | 2 | ||||||||
MIRT474351 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT477386 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT477452 | ELOVL1 | ELOVL fatty acid elongase 1 | 2 | 2 | ||||||||
MIRT479938 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT481633 | ARF1 | ADP ribosylation factor 1 | 2 | 2 | ||||||||
MIRT485404 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT486996 | ZFAND2B | zinc finger AN1-type containing 2B | 2 | 2 | ||||||||
MIRT488315 | LDOC1 | LDOC1, regulator of NFKB signaling | 2 | 2 | ||||||||
MIRT490609 | SLC47A1 | solute carrier family 47 member 1 | 2 | 4 | ||||||||
MIRT490686 | SSTR1 | somatostatin receptor 1 | 2 | 2 | ||||||||
MIRT490864 | UPK2 | uroplakin 2 | 2 | 2 | ||||||||
MIRT492572 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT492687 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT492939 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT494944 | IFFO2 | intermediate filament family orphan 2 | 2 | 2 | ||||||||
MIRT503137 | ATG9A | autophagy related 9A | 2 | 6 | ||||||||
MIRT507792 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT512248 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 4 | ||||||||
MIRT512585 | ZNF223 | zinc finger protein 223 | 2 | 2 | ||||||||
MIRT531029 | TDGF1P3 | teratocarcinoma-derived growth factor 1 pseudogene 3 | 2 | 2 | ||||||||
MIRT532014 | NOX5 | NADPH oxidase 5 | 2 | 2 | ||||||||
MIRT534906 | PUM2 | pumilio RNA binding family member 2 | 2 | 2 | ||||||||
MIRT555370 | PPP1R12A | protein phosphatase 1 regulatory subunit 12A | 2 | 2 | ||||||||
MIRT559524 | ARHGAP12 | Rho GTPase activating protein 12 | 2 | 4 | ||||||||
MIRT560005 | ZNF282 | zinc finger protein 282 | 2 | 2 | ||||||||
MIRT561566 | SLC6A9 | solute carrier family 6 member 9 | 2 | 2 | ||||||||
MIRT565714 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT568365 | AURKA | aurora kinase A | 2 | 2 | ||||||||
MIRT570343 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT573036 | GREM2 | gremlin 2, DAN family BMP antagonist | 2 | 2 | ||||||||
MIRT629706 | XKR4 | XK related 4 | 2 | 2 | ||||||||
MIRT649162 | IQSEC1 | IQ motif and Sec7 domain 1 | 2 | 2 | ||||||||
MIRT660691 | ANAPC1 | anaphase promoting complex subunit 1 | 2 | 2 | ||||||||
MIRT666940 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT694390 | MTA1 | metastasis associated 1 | 2 | 2 | ||||||||
MIRT704066 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT704316 | DCUN1D5 | defective in cullin neddylation 1 domain containing 5 | 2 | 2 | ||||||||
MIRT709848 | SNX12 | sorting nexin 12 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|